@eickelbergmd.bsky.social

Emanual Maverakis et al. use single-cell and bulk RNA-seq and immunohistochemistry to characterize necrobiosis and identified SPP1 and CCL5 as novel therapeutic targets for NL and NXG, rare diseases without a highly effective therapy: buff.ly/7htsyLe

Bild